Amil’s Founder Continues to Lead Company and Joins UnitedHealth’s BoardAmil’s founder, Dr. Edson Bueno, will continue to lead the company as chairman and CEO, and the experienced Amil leadership team will continue in their current positions. In addition, Dr. Bueno will bring his experience and knowledge of international health care and integrated care systems as a new member of UnitedHealth Group’s board of directors upon the transaction’s close. Richard Burke, chairman of the UnitedHealth Group board of directors said, “A highly trained and experienced physician and talented entrepreneur with deep expertise across the continuum of care, Dr. Bueno will be a strong addition to our board of directors. He is highly respected throughout Brazil, Latin America and in global health care circles.” UnitedHealth Group Preliminary Third Quarter Results UnitedHealth Group net earnings for the third quarter 2012 are expected to be a least $1.45 per share, with medical enrollment growth of over 650,000 people in the quarter and Optum clearly on its growth pace for the quarter and year. Medical costs remained well managed again this quarter. A full update on UnitedHealth Group’s third quarter earnings and expectations for the remainder of 2012 will be provided on its third quarter earnings call scheduled for October 16. Presentation Available; Analyst/Investor Conference Call Scheduled A presentation summarizing the Brazilian market and Amil’s position and results is available on the Investors page of UnitedHealth Group’s website at www.unitedhealthgroup.com Senior members of UnitedHealth Group and Amil’s management teams will discuss the new partnership with analysts and investors in a public conference call on October 8, 2012 at 8:45 a.m., Eastern Daylight Time. UnitedHealth Group will have an audio webcast from, and will post a copy of management’s remarks on the Investors page of its website at www.unitedhealthgroup.com. Investors can access the call at 866-952-1907 (domestic) and 785-424-1826 (international), passcode UNH1008. The Company recommends calling approximately 10-15 minutes before the start of the call. A replay of the call will be available for seven days and can be accessed at 800-677-6124 (domestic) and 402-220-0664 (international).